Table 1.
Baseline characteristics of patients with and without polycystic ovarian syndrome.
| Polycystic ovarian syndrome | p-value | ||
|---|---|---|---|
| No (n = 82,608) | Yes (n = 20,652) | ||
| Age (years), n (%) | 1.00 | ||
| ≤30 | 48,656 (58.9) | 12,164 (58.9) | |
| >30 | 33,952 (41.1) | 8,488 (41.1) | |
| Mean (SD) | 29.1 (6.8) | 29.0 (6.5) | 0.32 |
| Follow-up time (years) | |||
| Mean (SD) | 4.9 (3.5) | 4.8 (3.5) | 0.19 |
| Comorbidity, n (%) | |||
| Diabetes mellitus | 1,218 (1.5) | 1,048 (5.1) | <0.0001 |
| Hyperlipidemia | 1,858 (2.3) | 1,126 (5.5) | <0.0001 |
| COPD | 10,092 (12.2) | 3,302 (16.0) | <0.0001 |
| Asthma | 4,440 (5.4) | 1,480 (7.2) | <0.0001 |
| Chronic kidney disease | 975 (1.2) | 363 (1.8) | <0.0001 |
| Coronary artery disease | 781 (1.0) | 118 (0.6) | <0.0001 |
| Congestive heart failure | 120 (0.2) | 20 (0.1) | 0.19 |
COPD, chronic obstructive pulmonary disease; SD, standard deviation.